Skip to content
  • Argentina
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
  • Country/Region
    • Clinic Portal
      • +0034963905310
    • Request Information
    • +34 96 390 53 10
    • Part of brands: |
    InternationalInternational
    • Country/Region
      • Part of brands: |
      • We guide you
        • Fertility
          • What to do if…
        • Prevent Inherited Diseases
          • Carrier Genetic Test
        • Worry-free Pregnancy
          • NACE
          • Prenatal Diagnostics
          • Newborn Health
      • Reproductive Health
        • Specialists
          • ALICE
          • EMMA
          • ERA
          • EndomeTRIO
          • EMBRACE
          • CGT
          • NACE
          • Zenit
          • PGT-A
          • PGT-M
          • POC
          • SAT
          • Newborn Screening
        • Patients
          • ALICE
          • EMMA
          • ERA
          • EndomeTRIO
          • EMBRACE
          • CGT
          • NACE
          • Zenit
          • PGT-A
          • PGT-M
          • SAT
          • POC
      • Diagnostics
      • About us
        • Igenomix Research
        • About Igenomix
        • Igenomix Worldwide
      • Academy
      • Blog
      Genetic Solutions > CGT

      CGT: Carrier Genetic Test

      Determines the risk of having a child with a genetic disease

      CGT Carrier Genetic Test
      • Technical Overview
      • CGT Gene List
      • Residual risk
      • Documentation
      • Scientific evidence
      • I’m not a health specialist
    • CGT Carrier Genetic Test

      Inherited disorders represent 20% of the causes of infant mortality in developed countries

      CGT Carrier Genetic Test

      Sensitivity of 98%

      igenomix

      Different CGT options available: CGT Essential, CGT Plus and CGT Exome

      Test results in 20 working days

      Interested in learning more?

      Request information
      Or Email us at supportspain@igenomix.com
      Overview
      • CGT
      • Benefits
      • Indications

      What is CGT test?

      • CGT is an advanced carrier genetic test, which determines whether a couple are carriers of genetic mutations that could be transmitted to their children.
      • CGT uses Next-Generation Sequencing (NGS) to analyse a wide panel of disorders including as Cystic Fibrosis, Spinal Muscular Atrophy, Fragile-X Syndrome.
      Our New Universal approach to expanded carrier screening using Whole Exome Sequencing
      CGT Carrier Genetic Test

      CGT Exome

      Premium Expanded Panel compatible with most carrier platforms in the market.

      CGT Carrier Genetic Test

      CGT Plus

      Based on the recommendation of medical societies.

      CGT Bank

      Exclusive panel for Gamete donors

      More information about genes and mutations
      CGT Carrier Genetic Test

      Why use our CS Exome based?

      • Is a clinically validated genetic screening test based on Next-Generation Sequencing (NGS).
      • Allows for testing of all known recessive conditions, increasing the overall detection rate and minimizing the global residual risk.
      • Maximizes IVF applications, matching possible with all genetic lab tests in the market.
      • Our different CGT options, tailored to each patient’s needs, make it the most complete test available.
      • Any upgrade possible at a later date if required.
      • Genetic Counselling
      • Exome sequencing offers added value for a future analysis of a given patient providing analytical possibilities in an adverse event of a newborn with a genetic condition.

      Who should use CGT test?

      • Couples who plan on forming a family and want to know the risk of transmitting hereditary disorders to their children
      • Patients planning an assisted reproduction treatment
      • Patients planning a treatment with donor sperm or eggs

      Most carriers of genetic mutations don’t have a family history of these disorders.

      CGT Carrier Genetic Test

      Test limitations

      • The sensitivity of the test is 98%.
      • We only analyze genes on the list available at www.cgt.igenomix.com, reporting results based on knowledge current at the time of testing. Therefore, only genes included in this list will be detected.
      • The method is based on analysis by massive parallel sequencing and bioinformatics, studying all the exons of the genes included on our gene list. This includes adjacent intronic regions before or after position +5 and -5. Variants located outside the gene regions studied, such as gene-expression regulatory regions or intronic regions before or after position +5 and -5 are not detected.
      • No inversions, deletions, or duplications over 20 nucleotides long that are not referred to in the list available at www.cgt.igenomix.com are studied.
      • Germ mosaics (mutations only present in gametes) are not detected by this analysis because the DNA material studied is obtained from a blood sample.
      • A negative result for the genes indicated does not exclude the possibility that a de novo mutation may appear in the offspring.
      Documentation
      • CGT Specialists' documents

      Clinical Sheets

      Download

      Brochure

      Download

      Instructions

      Download
      Scientific evidence

      Relevant related studies:

      The development of the CGT panel and the concept of comprehensive carrier screening was published in a paper by Martin et al, 2015 (Fertil Steril. 2015 Nov; 104(5):1286-93).

      An analysis of preconception carrier screening and genetic matching with donor gametes was presented in an abstract by Egea et al, 2016 (Fertil Steril. 2016 Oct; e329).

      Results discussing the use of carrier screening to predict the risk of disorders in the Middle-Eastern population was published as an abstract by Martin et al, 2018 (Reproductive Biomedicine Online 2018; e10)

      FAQs

      Opening hours, contact details, lab address...

      User manual

      If you're a little lost with this technical information...

      Can we help you?

      I’m not a health specialist

      Igenomix and fertility

      We work to make a world in which infertility is no longer an impossible barrier. Together with clinics and fertility specialists worldwide, we investigate human reproduction to change the lives of those who are trying to conceive.

      Learn more about Igenomix

      Other services

      PGT-M Preimplantation Genetic Testing

      PGT-M

      Prevents the transmission of single gene disorders

      More information
      NACE Non-invasive prenatal test

      NACE

      Minimizes unnecessary amniocentesis

      More information

      Igenomix is in the media

      WE GUIDE YOU

      Fertility
      Inherited diseases prevention
      Healthy pregnancy

      To see the accreditation certificate, associated technical annex and list of accredited tests, click on this link.

      OUR SERVICES

      Genetic solutions
      For patients
      How to send a sample?
      User manual

      ABOUT US

      About Igenomix
      Contact
      Quality
      Complaints
      Work with us

      FOLLOW IGENOMIX

        + 96 390 53 10
        Write us
      • Argentina
      • Brazil
      • Canada
      • Chile
      • Colombia
      • Europe
      • France
      • Germany
      • India
      • Italy
      • Japan
      • Korea
      • Mexico
      • Perú
      • Russia
      • Spain
      • Taiwan
      • The Middle East
      • Turkey
      • United Kingdom
      • United States
      • Vietnam
      Country/Region

      [2021] © Igenomix Privacy policy Quality policy Legal note Cookies policyNews and Press

      Request Information

















      • We guide you
        • Fertility
          • What to do if…
        • Prevent Inherited Diseases
          • Carrier Genetic Test
        • Worry-free Pregnancy
          • NACE
          • Prenatal Diagnostics
          • Newborn Health
      • Reproductive Health
        • Specialists
          • ALICE
          • EMMA
          • ERA
          • EndomeTRIO
          • EMBRACE
          • CGT
          • NACE
          • Zenit
          • PGT-A
          • PGT-M
          • POC
          • SAT
          • Newborn Screening
        • Patients
          • ALICE
          • EMMA
          • ERA
          • EndomeTRIO
          • EMBRACE
          • CGT
          • NACE
          • Zenit
          • PGT-A
          • PGT-M
          • SAT
          • POC
      • Diagnostics
      • About us
        • Igenomix Research
        • About Igenomix
        • Igenomix Worldwide
      • Academy
      • Blog
      • Country/Region
      • +34 96 390 53 10
      • Clinic Portal
      • Request Information

      We are using cookies to give you the best experience on our website.

      You can find out more about which cookies we are using or switch them off in settings.

      International
      Powered by  GDPR Cookie Compliance
      Privacy Overview

      This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

      Strictly Necessary Cookies

      Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

      If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

      3rd Party Cookies

      This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

      Keeping this cookie enabled helps us to improve our website.

      Please enable Strictly Necessary Cookies first so that we can save your preferences!

      Cookie Policy

      More information about our Cookie Policy